当前位置:首页 - 行情中心 - 欧林生物(688319) - 财务分析 - 现金流量表

欧林生物

(688319)

  

流通市值:154.22亿  总市值:154.33亿
流通股本:4.05亿   总股本:4.06亿

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金130,972,177.88641,599,397.99425,324,997.51237,674,014.5
  收到其他与经营活动有关的现金5,988,547.8729,217,496.1614,729,823.611,620,766.67
  经营活动现金流入小计136,960,725.75670,816,894.15440,054,821.11249,294,781.17
  购买商品、接受劳务支付的现金10,871,506.8639,402,719.7428,939,100.7421,283,596.59
  支付给职工以及为职工支付的现金36,455,088.02102,152,012.1379,077,061.0757,240,194.48
  支付的各项税费22,102,942.5652,136,375.933,371,389.2521,604,554.53
  支付其他与经营活动有关的现金92,955,776.82371,632,009.02265,622,035.11168,905,116.09
  经营活动现金流出小计162,385,314.26565,323,116.79407,009,586.17269,033,461.69
  经营活动产生的现金流量净额-25,424,588.51105,493,777.3633,045,234.94-19,738,680.52
二、投资活动产生的现金流量:
  收回投资收到的现金135,000,000200,000,00095,000,00035,000,000
  取得投资收益收到的现金125,136.99497,841.77259,436.3150,511.64
  处置固定资产、无形资产和其他长期资产收回的现金净额-27,730.827,730.827,730.8
  投资活动现金流入小计135,125,136.99200,525,572.5795,287,167.135,178,242.44
  购建固定资产、无形资产和其他长期资产支付的现金22,909,127.3698,811,383.2667,669,448.6939,268,914.08
  投资支付的现金135,000,000224,209,072.32125,100,00035,100,000
  投资活动现金流出小计157,909,127.36323,020,455.58192,769,448.6974,368,914.08
  投资活动产生的现金流量净额-22,783,990.37-122,494,883.01-97,482,281.59-39,190,671.64
三、筹资活动产生的现金流量:
  取得借款收到的现金20,000,000176,100,000125,000,00095,000,000
  筹资活动现金流入小计20,000,000176,100,000125,000,00095,000,000
  偿还债务支付的现金15,530,000114,720,000102,310,00068,580,000
  分配股利、利润或偿付利息支付的现金4,120,229.3714,716,571.5910,605,464.357,329,320.79
  支付其他与筹资活动有关的现金6,453,170.4922,263,172.242,138,263.2-
  筹资活动现金流出小计26,103,399.86151,699,743.83115,053,727.5575,909,320.79
  筹资活动产生的现金流量净额-6,103,399.8624,400,256.179,946,272.4519,090,679.21
五、现金及现金等价物净增加额-54,311,978.747,399,150.52-54,490,774.2-39,838,672.95
  加:期初现金及现金等价物余额225,175,981.53217,776,831.01217,776,831.01217,776,831.01
  期末现金及现金等价物余额170,864,002.79225,175,981.53163,286,056.81177,938,158.06
补充资料:
  净利润-21,898,737.19-13,229,790.42
  资产减值准备-13,585,517.39--491,601.37
  固定资产和投资性房地产折旧-33,178,368.49-15,774,126.48
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-33,178,368.49-15,774,126.48
  无形资产摊销-1,531,603.18-628,784.7
  长期待摊费用摊销-4,105,544.24-2,065,184.07
  处置固定资产、无形资产和其他长期资产的损失--8,707.5--8,707.05
  固定资产报废损失---14,669.24
  财务费用-14,987,126.18-7,455,488.08
  投资损失--497,841.77--150,511.64
  递延所得税--762,860.6--
  其中:递延所得税资产减少--6,698,699.4--
    递延所得税负债增加-5,935,838.8--
  存货的减少-9,713,212.89-9,644,591.23
  经营性应收项目的减少--84,654,805.22--104,984,738.88
  经营性应付项目的增加-75,133,339.27-3,394,391.26
  现金的期末余额-225,175,981.53-177,938,158.06
  减:现金的期初余额-217,776,831.01-217,776,831.01
  现金及现金等价物的净增加额-7,399,150.52--39,838,672.95
公告日期2026-04-302026-03-312025-10-302025-08-29
审计意见(境内)标准无保留意见
TOP↑